Respiratory Sarcopenia in Institutionalized Older Adults in the Region of Murcia
1 other identifier
observational
127
1 country
1
Brief Summary
Objectives: The objectives of this study are to describe the prevalence of respiratory sarcopenia in institutionalized older adults. Methodology: A sample of approximately 120 older adults from 5 residences located in Murcia capital will participate in the study. A prospective observational study will be carried out, with one year of follow-up, with patients who have been diagnosed with respiratory sarcopenia. Sociodemographic and clinical variables, physical function (palm grip, 5STS, 4MGS), respiratory force variables (MIP and PEF) and diaphragmatic ultrasound (thickness, shortening fraction and diaphragmatic excursion) will be measured. Descriptive statistics, univariate and multivariate logistic regression models, Cox proportional hazards model and KaplanMeier curves will be used to analyze the data from the longitudinal study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2023
CompletedFirst Submitted
Initial submission to the registry
October 30, 2023
CompletedFirst Posted
Study publicly available on registry
November 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2025
CompletedAugust 20, 2025
January 1, 2024
8 months
October 30, 2023
August 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Sociodemographic
Sociodemographic dates
8 MONTHS
Clinical variables
Clinical variables will be extracted from history clinic
8 MONTHS
Palm grip strength
Palm grip strength will be measured with the digital hand dynamometer (Jamar©). The Participants will remain seated with the shoulder in 0° adduction; elbow flexed 90° and forearm in neutral position. Three attempts will be made and the best value will be chosen
8 MONTHS
5 SIT TO STAND
The 5STS test measures the time (in seconds) it takes a subject to stop 5 times from a sitting position, as quickly as possible.
8 MONTHS
4 METRES
The gait speed test (4MGS) measures the time it takes to cross a line of 4m at normal speed.
8 MONTS
Body composition
\- The analysis of body composition will be carried out with the TANITA MC 780-P MA monitor, which provides information on visceral and body fat, skeletal muscle level, BMI and basal metabolism.
8 MONTHS
Respiratoy muscle force
To measure respiratory muscle force, the maximum respiratory pressures will be evaluated in mouth (PIM/PEM). For them we will use an inspiratory and expiratory mouth pressure monitor maximum, a module of the Datapir touch© spirometer (Sibelmed, Barcelona). The measurement will be performed by a previously trained and experienced physiotherapist, following the protocol established by the Spanish Society of Pulmonology (4-SEPAR).
8 MONTHS
Diaphragmatic ultrasound variables
The diaphragmatic ultrasound variables examined will be mobility, thickness and fraction of shortening. For this we will use the Esaote MyLab™ Sigma ultrasound machine (Esaote SpA, Genoa, Italy), with double probe (linear and convex).
8 MONTHS
Secondary Outcomes (1)
Health results
8 MONTHS
Study Arms (2)
Wheelchair
The inclusion criteria to participate in the study are being in a wheelchair, preserved cognitive status and having sufficient ability to Oral occlusion for carrying out respiratory tests. The exclusion criteria are following: presence of respiratory diseases or in treatment of respiratory diseases, serious orthopedic diseases that interfere with measurements and those with a diagnosis of dementia. In addition, those who present any contraindication for carrying out the procedure will be excluded. of the respiratory pressure measurement tests, as established in the SEPAR guidelines. The objectives of the study and the methodology to be used will be explained to all participants. An information sheet will be provided and the informed consent sheet will be given to them.
wanderers
The inclusion criteria to participate in the study are to have functional ambulation, preserved cognitive status and have sufficient ability to Oral occlusion for carrying out respiratory tests. The exclusion criteria are following: presence of respiratory diseases or in treatment of respiratory diseases, serious orthopedic diseases that interfere with measurements and those with a diagnosis of dementia. In addition, those who present any contraindication for carrying out the procedure will be excluded. of the respiratory pressure measurement tests, as established in the SEPAR guidelines. The objectives of the study and the methodology to be used will be explained to all participants. An information sheet will be provided and the informed consent sheet will be given to them.
Eligibility Criteria
Institutionalized elderly diagnosed with respiratory sarcopenia
You may qualify if:
- To have functional ambulation and/or wheelchair.
- preserved cognitive status.
- have sufficient ability to Oral occlusion for carrying out respiratory tests.
You may not qualify if:
- presence of respiratory diseases or in treatment of respiratory diseases.
- serious orthopedic diseases that interfere with measurements and those with a diagnosis of dementia.
- those who present any contraindication for carrying out the procedure will be excluded.
- of the respiratory pressure measurement tests, as established in the SEPAR guidelines.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Residence of the elderly
Murcia, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Investigator
Study Record Dates
First Submitted
October 30, 2023
First Posted
November 14, 2023
Study Start
May 1, 2023
Primary Completion
December 31, 2023
Study Completion
July 31, 2025
Last Updated
August 20, 2025
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share